HCAT vs TEM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

HCAT

38.7
AI Score
VS
TEM Wins

TEM

41.3
AI Score

Investment Advisor Scores

HCAT

39score
Recommendation
SELL

TEM

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HCAT TEM Winner
Revenue 141.24M 730.60M TEM
Net Income -151.56M -120.28M TEM
Net Margin -107.3% -16.5% TEM
Operating Income -142.96M -160.62M HCAT
ROE -150.3% -27.0% TEM
ROA -42.3% -5.1% TEM
Total Assets 358.60M 2.37B TEM
Cash 60.59M 599.61M TEM
Current Ratio 2.70 3.30 TEM
Free Cash Flow 18.10M -95.13M HCAT

Relative Price Performance (Last 90 Days)

HCAT 1M: -23.9% · 3M: +18.6% TEM 1M: +58.0% · 3M: +56.4%

Current Technical Phase

HCAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 32

RSI (14): 32.4 · Price: $1.53

TEM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 75

RSI (14): 75.2 · Price: $72.69

Fundamentals Snapshot

Metric HCAT TEM
Market Cap
Forward P/E 38.4 -4384.9
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% 0.2%
Gross Margin 0.5% 0.6%
Operating Margin -0.1% -0.2%
EPS -3.54 -1.79
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, TEM is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.